298 related articles for article (PubMed ID: 20937980)
21. Evaluation of superparamagnetic iron oxide for MR imaging of liver injury: proton relaxation mechanisms and optimal MR imaging parameters.
Tanimoto A; Mukai M; Kuribayashi S
Magn Reson Med Sci; 2006 Jul; 5(2):89-98. PubMed ID: 17008765
[TBL] [Abstract][Full Text] [Related]
22. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging.
Kooi ME; Cappendijk VC; Cleutjens KB; Kessels AG; Kitslaar PJ; Borgers M; Frederik PM; Daemen MJ; van Engelshoven JM
Circulation; 2003 May; 107(19):2453-8. PubMed ID: 12719280
[TBL] [Abstract][Full Text] [Related]
23. Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labeling.
Yancy AD; Olzinski AR; Hu TC; Lenhard SC; Aravindhan K; Gruver SM; Jacobs PM; Willette RN; Jucker BM
J Magn Reson Imaging; 2005 Apr; 21(4):432-42. PubMed ID: 15779033
[TBL] [Abstract][Full Text] [Related]
24. Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model.
Sigovan M; Boussel L; Sulaiman A; Sappey-Marinier D; Alsaid H; Desbleds-Mansard C; Ibarrola D; Gamondès D; Corot C; Lancelot E; Raynaud JS; Vives V; Laclédère C; Violas X; Douek PC; Canet-Soulas E
Radiology; 2009 Aug; 252(2):401-9. PubMed ID: 19703881
[TBL] [Abstract][Full Text] [Related]
25. Identifying Vulnerable Atherosclerotic Plaque in Rabbits Using DMSA-USPIO Enhanced Magnetic Resonance Imaging to Investigate the Effect of Atorvastatin.
Qi C; Deng L; Li D; Wu W; Gong L; Li Y; Zhang Q; Zhang T; Zhang C; Zhang Y
PLoS One; 2015; 10(5):e0125677. PubMed ID: 25973795
[TBL] [Abstract][Full Text] [Related]
26. Detection of Vulnerable Atherosclerotic Plaques in Experimental Atherosclerosis with the USPIO-Enhanced MRI.
Qi CM; Du L; Wu WH; Li DY; Hao J; Gong L; Deng L; Zhang T; Zhang C; Zhang Y
Cell Biochem Biophys; 2015 Nov; 73(2):331-337. PubMed ID: 27352319
[TBL] [Abstract][Full Text] [Related]
27. Contrast-enhanced MR imaging of atherosclerosis using citrate-coated superparamagnetic iron oxide nanoparticles: calcifying microvesicles as imaging target for plaque characterization.
Wagner S; Schnorr J; Ludwig A; Stangl V; Ebert M; Hamm B; Taupitz M
Int J Nanomedicine; 2013; 8():767-79. PubMed ID: 23450179
[TBL] [Abstract][Full Text] [Related]
28. Erythrocyte membrane cholesterol and lipid core growth in a rabbit model of atherosclerosis: modulatory effects of rosuvastatin.
Tziakas D; Chalikias G; Kapelouzou A; Tentes I; Schäfer K; Karayannakos P; Kostakis A; Boudoulas H; Konstantinides S
Int J Cardiol; 2013 Dec; 170(2):173-81. PubMed ID: 24215985
[TBL] [Abstract][Full Text] [Related]
29. Ferumoxtran-10-enhanced MRI of the hypercholesterolemic rabbit aorta: relationship between signal loss and macrophage infiltration.
Hyafil F; Laissy JP; Mazighi M; Tchétché D; Louedec L; Adle-Biassette H; Chillon S; Henin D; Jacob MP; Letourneur D; Feldman LJ
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):176-81. PubMed ID: 16269663
[TBL] [Abstract][Full Text] [Related]
30. Atherosclerotic aortic component quantification by noninvasive magnetic resonance imaging: an in vivo study in rabbits.
Helft G; Worthley SG; Fuster V; Zaman AG; Schechter C; Osende JI; Rodriguez OJ; Fayad ZA; Fallon JT; Badimon JJ
J Am Coll Cardiol; 2001 Mar; 37(4):1149-54. PubMed ID: 11263622
[TBL] [Abstract][Full Text] [Related]
31. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
[No Abstract] [Full Text] [Related]
32. The use of plaque score measurements to assess changes in atherosclerotic plaque burden induced by lipid-lowering therapy over time: the METEOR study.
Peters SA; Dogan S; Meijer R; Palmer MK; Grobbee DE; Crouse JR; O'Leary DH; Evans GW; Raichlen JS; Bots ML
J Atheroscler Thromb; 2011; 18(9):784-95. PubMed ID: 21617330
[TBL] [Abstract][Full Text] [Related]
33. FDG-PET can distinguish inflamed from non-inflamed plaque in an animal model of atherosclerosis.
Davies JR; Izquierdo-Garcia D; Rudd JH; Figg N; Richards HK; Bird JL; Aigbirhio FI; Davenport AP; Weissberg PL; Fryer TD; Warburton EA
Int J Cardiovasc Imaging; 2010 Jan; 26(1):41-8. PubMed ID: 19784796
[TBL] [Abstract][Full Text] [Related]
34. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease.
Tang TY; Howarth SP; Miller SR; Graves MJ; Patterson AJ; U-King-Im JM; Li ZY; Walsh SR; Brown AP; Kirkpatrick PJ; Warburton EA; Hayes PD; Varty K; Boyle JR; Gaunt ME; Zalewski A; Gillard JH
J Am Coll Cardiol; 2009 Jun; 53(22):2039-50. PubMed ID: 19477353
[TBL] [Abstract][Full Text] [Related]
35. Dual-energy CT imaging of atherosclerotic plaque using novel ultrasmall superparamagnetic iron oxide in hyperlipidemic rabbits.
Sato H; Fujimoto S; Kawaguchi YO; Nozaki YO; Tomizawa N; Kogure Y; Minamino T
Acta Radiol; 2023 Apr; 64(4):1718-1724. PubMed ID: 36226361
[TBL] [Abstract][Full Text] [Related]
36. Use of contrast enhancement and high-resolution 3D black-blood MRI to identify inflammation in atherosclerosis.
Hur J; Park J; Kim YJ; Lee HJ; Shim HS; Choe KO; Choi BW
JACC Cardiovasc Imaging; 2010 Nov; 3(11):1127-35. PubMed ID: 21071000
[TBL] [Abstract][Full Text] [Related]
37. Imaging of the inflammatory response in reperfusion injury after transient cerebral ischemia in rats: correlation of superparamagnetic iron oxide-enhanced magnetic resonance imaging with histopathology.
Kim J; Kim DI; Lee SK; Kim DJ; Lee JE; Ahn SK
Acta Radiol; 2008 Jun; 49(5):580-8. PubMed ID: 18568546
[TBL] [Abstract][Full Text] [Related]
38. Early identification of aortic valve sclerosis using iron oxide enhanced MRI.
Hamilton AM; Rogers KA; Belisle AJ; Ronald JA; Rutt BK; Weissleder R; Boughner DR
J Magn Reson Imaging; 2010 Jan; 31(1):110-6. PubMed ID: 20027578
[TBL] [Abstract][Full Text] [Related]
39. The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation.
Calkin AC; Giunti S; Sheehy KJ; Chew C; Boolell V; Rajaram YS; Cooper ME; Jandeleit-Dahm KA
Diabetologia; 2008 Sep; 51(9):1731-40. PubMed ID: 18594792
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
